<DOC>
	<DOCNO>NCT00004495</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare efficacy two dose folic acid normalize plasma total homocysteine concentration patient end stage renal disease receive regular hemodialysis therapy result hyperhomocysteinemia . II . Determine requirement co-supplementation extra pyridoxine ( vitamin B6 ) cyanocobalamin ( vitamin B12 ) daily patient . III . Assess safety tolerability therapy patient .</brief_summary>
	<brief_title>Randomized Study Folic Acid Therapy Hyperhomocysteinemia Patients With End Stage Renal Disease Receiving Hemodialysis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , placebo control study . Patients stratify accord prestudy homocysteine level ( average ) . Patients randomize receive placebo one two dose oral folic acid , without pyridoxine cyanocobalamin . Arm I : Patients receive oral placebo daily . Arm II : Patients receive oral pyridoxine , cyanocobalamin , oral placebo daily . Arm III : Patients receive oral pyridoxine , cyanocobalamin , folic acid daily . Arm IV : Patients receive oral pyridoxine cyanocobalamin plus high dose folic acid daily . Arm V : Patients receive oral placebo oral folic acid daily . Arm VI : Patients receive oral placebo high dose folic acid daily . Treatment continue 8 week . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperhomocysteinemia</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis end stage renal disease require regular hemodialysis treatment 3 time weekly Baseline predialysis total homocysteine concentration plasma great 16 micromoles/L No prior concurrent pernicious anemia No blood smear examination show unexplained macrocytosis Prior/Concurrent Therapy Chemotherapy : No concurrent chemotherapy cancer Other : No concurrent levodopa carbidopa No concurrent penicillamine trimethoprimsulfonamide combination No concurrent antiviral therapy No concurrent anticonvulsant Patient Characteristics Hematopoietic : Hematocrit least 25 % Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No Parkinson 's disease No convulsion epilepsy require treatment No lactose intolerance allergy milk product No history allergic sensitization follow administration folic acid , pyridoxine ( vitamin B6 ) , cyanocobalamin ( vitamin B12 ) No vitamin B12 concentration lower limit normal ( 150 picamole/L ) No untreated hypothyroidism psoriasis</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>August 1999</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>end stage renal disease</keyword>
	<keyword>hyperhomocysteinemia</keyword>
	<keyword>rare disease</keyword>
	<keyword>renal genitourinary disorder</keyword>
</DOC>